A
Astrid van Tubergen
Researcher at Public Health Research Institute
Publications - 114
Citations - 5796
Astrid van Tubergen is an academic researcher from Public Health Research Institute. The author has contributed to research in topics: Medicine & Ankylosing spondylitis. The author has an hindex of 35, co-authored 93 publications receiving 4601 citations. Previous affiliations of Astrid van Tubergen include Leiden University Medical Center & Maastricht University Medical Centre.
Papers
More filters
Journal ArticleDOI
Radiographic findings following two years of infliximab therapy in patients with ankylosing spondylitis.
Désirée van der Heijde,Robert Landewé,Xenofon Baraliakos,Harry Houben,Astrid van Tubergen,Paul Williamson,W. Xu,Daniel Baker,Neil Goldstein,Jürgen Braun +9 more
TL;DR: AS patients who received infliximab from baseline through week 96 did not show a statistically significant difference in inhibition of structural damage progression at year 2, as assessed using the mSASSS scoring system, when compared with radiographic data from the historical control OASIS cohort.
Journal ArticleDOI
Combined spa-exercise therapy is effective in patients with ankylosing spondylitis: a randomized controlled trial.
Astrid van Tubergen,Robert Landewé,Désirée van der Heijde,A. Hidding,Nico Wolter,Max Asscher,Albrecht Falkenbach,Ekkehard Genth,Sjef van der Linden +8 more
TL;DR: In patients with AS, a 3-week course of combined spa-exercise therapy, in addition to drug treatment and weekly group physical therapy alone, provides beneficial effects, and these beneficial effects may last for at least 40 weeks.
Journal ArticleDOI
Prevalence of extra-articular manifestations in patients with ankylosing spondylitis: a systematic review and meta-analysis
TL;DR: The aim of the present study was to summarise the prevalence of EAMs among patients with AS and to identify underlying factors to explain potential heterogeneity of prevalence, which can be partly explained by differences in clinical as well as methodological characteristics.
Journal ArticleDOI
Lack of placental transfer of certolizumab pegol during pregnancy: results from CRIB, a prospective, postmarketing, pharmacokinetic study.
Xavier Mariette,Frauke Förger,Bincy Abraham,Ann D. Flynn,Anna Molto,René Marc Flipo,Astrid van Tubergen,Laura Shaughnessy,Jeff Simpson,Marie Teil,Eric Helmer,Maggie Wang,Eliza F. Chakravarty +12 more
TL;DR: There was no to minimal placental transfer of CZP from mothers to infants, suggesting lack of in utero foetal exposure during the third trimester, and results support continuation of CzP treatment during pregnancy, when considered necessary.
Journal Article
Prevalence of extra-articular manifestations in patients with ankylosing spondylitis : a systematic review and meta-analysis
TL;DR: In this paper, a systematic literature search was performed to identify the prevalence of EAMs among patients with ankylosing spondylitis (AS) and to identify underlying factors to explain potential heterogeneity of prevalence.